MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Olfactory dysfunction"

  • 2016 International Congress

    Evolution of mild Parkinsonian signs in a longitudinal population-based cohort

    J. Hampf, S. Tunc, J. Graf, K. Hückelheim, E.J. Vollstedt, B. Staemmler, C. Klein, M. Kasten (Luebeck, Germany)

    Objective: To investigate evolution of mild Parkinsonian signs (MPS) in an ongoing longitudinal study on Parkinson's disease (PD). Background: Mild motor impairmant may progress to…
  • 2016 International Congress

    The patterns of olfactory function in Parksinson’s disease patients with mild cognitive impairment

    J.W. Park, H.K. Yoon, M.H. Park, D.Y. Kwon (Ansan, Korea)

    Objective: To examine relationship between olfactory dysfunction and PD-MCI, and investigated the patterns of olfactory function in subtypes of PD-MCI patients using the Korean version…
  • 2016 International Congress

    Analysis of the olfactory impairments in PINK1 deficient mice

    A. Hummel, A. Zimprich, L. Garret, B. Sperling, F. Giesert, J. Nagler, H. Fuchs, V. Gailus-Durner, M. Hrabé de Angelis, S.M. Koch, D. Vogt Weisenhorn, W. Wurst (Neuherberg, Germany)

    Objective: To explore the olfactory effect of PINK1 deficiency in serotonergic and dopaminergic neurons we did a behavioral analysis of young mice, deficient for PINK1…
  • 2016 International Congress

    Dophaminergic therapy and its influence on the olfactory function of patients with Parkinson’s disease

    O. Izhboldina, I. Zhukova, N. Zhukova, V. Alifirova, A. Latypova, M. Nikitina, Y. Mironova (Tomsk, Russia)

    Objective: The aim of this study was to investigate effects of dophaminergic therapy on olfaction of patients with Parkinson's disease. Background: Influence of dopaminergic drugs…
  • 2016 International Congress

    Neuropsychological assessment in the Luxembourg Parkinson’s cohort (HELP-PD)

    G. Hipp, P. Kolber, K. Roomp, M. Kerschenmeyer, S.K. Mosch, L. Longhino, A. Schweicher, M. Faltz, V.P. Satagopam, N. Goncharenko, M. Gantenbein, M. Vaillant, F. Betsou, A. Chioti, R. Schneider, R. Schneider, R. Balling, N.J. Diederich, R. Krüger (Belvaux, Luxembourg)

    Objective: To report first results on the prevalence of cognitive non-motor symptoms in the Luxembourg Parkinson's cohort (HELP-PD). Background: HELP-PD aims to combine thorough assessment…
  • 2016 International Congress

    Motor rigidity selectively associates with impaired odor identification in Parkinson’s disease

    J.D. Haugen, M.L.T.M. Muller, V. Kotagal, K.A. Frey, R.L. Albin, N.I. Bohnen (Ann Arbor, MI, USA)

    Objective: To investigate the relationship between impairments of the cardinal motor symptoms and odor identification deficits in Parkinson's disease (PD). Background: Although hyposmia has been…
  • 2016 International Congress

    Allele specificity in neurodegenerative olfactory dysfunction

    B.A. Chase, K. Markopoulou, P. Robowski, A. Strongosky, E. Narozanska, E.J. Sitek, M. Berdynski, M. Barcikowska, M.C. Baker, R. Radamakers, J. Slawek, Z.K. Wszolek (Omaha, NE, USA)

    Objective: Assess olfactory dysfunction in carriers of the p.N279K and p.P301L MAPT mutations, which cause FTDP-17, to understand how genotypic differences contribute to the severity…
  • 2016 International Congress

    Sniffing the diagnosis: Olfactory testing in neurodegenerative parkinsonism

    F. Krismer, B. Pinter, C. Müller, P. Mahlknecht, M. Nocker, E. Reiter, A. Djamshidian-Tehrani, S.M. Bösch, G.K. Wenning, C. Scherfler, W. Poewe, K. Seppi (Innsbruck, Austria)

    Objective: To determine the diagnostic utility of olfactory testing in patients with neurodegenerative parkinsonism. Background: Olfactory dysfunction can be identified in the vast majority of…
  • 2016 International Congress

    Parkinsonism risk factors in Salt Lake City, Utah

    D. Shprecher, K. Gannon, M. Halverson, R. Savica (Sun City, AZ, USA)

    Objective: To assess the prevalence of risk factors for parkinsonism in Salt Lake City (SLC), Utah. Background: Recent data suggest that non-motor symptoms including constipation,…
  • 2016 International Congress

    Motor features and response to levodopa in Parkinson’s disease with normal olfactory function

    M. Rossi, A. Medina Escobar, A. Bril, P. Millar Vernetti, J.I. De Palo, D. Cerquetti, M. Merello (Buenos Aires, Argentina)

    Objective: The aim of this study was to evaluate motor features in the OFF and ON states and the acute levodopa response in Parkinson's disease…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley